Cspc Pharmaceutical reported CNY1.89B in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
Avita Medical AUD 21.23M 2.57M Dec/2024
Cspc Pharmaceutical CNY 1.89B 347.81M Mar/2025
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Jiangsu Hengrui CNY 3.12B 575.34M Jun/2025
Kangmei Pharma CNY 259.36M 49.8M Jun/2025
Moderna USD 230M 18M Jun/2025
Organon & Co USD 453M 33M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Sh Fosun Pharma CNY 3.14B 30.87M Jun/2025
Sino Biopharmaceutical CNY 5.31B 1.54B Dec/2024
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Viatris USD 928.7M 111.2M Jun/2025
Wuxi Apptec CNY 812.94M 22.68M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025
Zz Pientze Pharmaceu -171290000 342.58M Jun/2025